MX2012013222A - Composicion de vehiculos y formas farmaceuticas de liberacion sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros farmacos en aves comericales y cerdos. - Google Patents

Composicion de vehiculos y formas farmaceuticas de liberacion sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros farmacos en aves comericales y cerdos.

Info

Publication number
MX2012013222A
MX2012013222A MX2012013222A MX2012013222A MX2012013222A MX 2012013222 A MX2012013222 A MX 2012013222A MX 2012013222 A MX2012013222 A MX 2012013222A MX 2012013222 A MX2012013222 A MX 2012013222A MX 2012013222 A MX2012013222 A MX 2012013222A
Authority
MX
Mexico
Prior art keywords
drugs
composition
excipients
pharmaceutical forms
pigs
Prior art date
Application number
MX2012013222A
Other languages
English (en)
Other versions
MX347401B (es
Inventor
Héctor Salvador Sumano López
Lilia Gutiérrez Olvera
Original Assignee
Univ Nac Autónoma De México
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nac Autónoma De México filed Critical Univ Nac Autónoma De México
Priority to MX2012013222A priority Critical patent/MX347401B/es
Priority to CN201380065077.0A priority patent/CN105050599A/zh
Priority to BR112015010980A priority patent/BR112015010980A8/pt
Priority to US14/442,610 priority patent/US20160279063A1/en
Priority to PCT/MX2013/000137 priority patent/WO2014077666A1/es
Publication of MX2012013222A publication Critical patent/MX2012013222A/es
Priority to SV2015004970A priority patent/SV2015004970A/es
Priority to DO2015000111A priority patent/DOP2015000111A/es
Publication of MX347401B publication Critical patent/MX347401B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición de vehículos y formas farmacéuticas de liberación sostenida y aumento de biodisponibilidad de fármaco para aves y cerdos y procedimiento para su preparación, dicha composición comprende: agentes farmacéuticamente activos, agentes promotores de la biodisponibilidad, polímeros de liberación prolongada del fármaco, colorantes, y saborizantes. La composición de vehículos y formas farmacéuticas de la presente invención optimiza la dosificación del fármaco y genera cepas resistentes de bacterias por optimización de la relación entre farmacocinética/farmacodinam ia de fármacos. La composición se presenta en diferentes formas y colores que permiten identificación del producto y mejor aceptación por parte del ave o del cerdo.
MX2012013222A 2012-11-14 2012-11-14 Composicion de vehiculos y formas farmaceuticas de liberacion sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros farmacos en aves comericales y cerdos. MX347401B (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
MX2012013222A MX347401B (es) 2012-11-14 2012-11-14 Composicion de vehiculos y formas farmaceuticas de liberacion sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros farmacos en aves comericales y cerdos.
CN201380065077.0A CN105050599A (zh) 2012-11-14 2013-11-14 具有缓释及提高抗菌药物、抗球虫药物及其它药物在商业家禽和猪上的生物利用度的赋形剂和药物剂型的组合物
BR112015010980A BR112015010980A8 (pt) 2012-11-14 2013-11-14 composição de veículos e formas farmacêuticas de liberação prolongada e aumento de biodisponibilidade de antibacterianos, anticoccidianos e outros fármacos em aves comerciais e porcos
US14/442,610 US20160279063A1 (en) 2012-11-14 2013-11-14 Composition of excipients and pharmaceutical forms with sustained release and increased bioavailability of antibacterial drugs, anticoccidial drugs and other drugs for commercial poultry and pigs
PCT/MX2013/000137 WO2014077666A1 (es) 2012-11-14 2013-11-14 Composición de vehículos y formas farmacéuticas de liberación sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros fármacos en aves comerciales y cerdos
SV2015004970A SV2015004970A (es) 2012-11-14 2015-05-11 Composición de vehículos y formas farmacéuticas de liberación sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros fármacos en aves comerciales y cerdos
DO2015000111A DOP2015000111A (es) 2012-11-14 2015-05-14 Composición de vehículos y formas farmacéuticas de liberación sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros fármacos en aves comerciales y cerdos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012013222A MX347401B (es) 2012-11-14 2012-11-14 Composicion de vehiculos y formas farmaceuticas de liberacion sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros farmacos en aves comericales y cerdos.

Publications (2)

Publication Number Publication Date
MX2012013222A true MX2012013222A (es) 2014-05-22
MX347401B MX347401B (es) 2017-04-18

Family

ID=50731496

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012013222A MX347401B (es) 2012-11-14 2012-11-14 Composicion de vehiculos y formas farmaceuticas de liberacion sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros farmacos en aves comericales y cerdos.

Country Status (7)

Country Link
US (1) US20160279063A1 (es)
CN (1) CN105050599A (es)
BR (1) BR112015010980A8 (es)
DO (1) DOP2015000111A (es)
MX (1) MX347401B (es)
SV (1) SV2015004970A (es)
WO (1) WO2014077666A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104127429A (zh) * 2014-07-28 2014-11-05 邳州正康生物技术有限公司 一种用于防治畜禽呼吸道疾病的饮水剂及其制备方法
CN105878228B (zh) * 2016-06-27 2018-05-18 河北天元药业有限公司 一种延胡索酸泰妙菌素可溶性粉及其制备方法
CN111479565A (zh) * 2017-10-20 2020-07-31 艾克西化学公司 作为生物增强剂的合成辣椒碱类似物
CN107648616A (zh) * 2017-10-27 2018-02-02 四川康四海动物药业有限公司 一种替米考星包合工艺
CN108484693B (zh) * 2018-03-14 2020-08-11 中科荣信（苏州）生物科技有限公司 一种壳寡糖-抗生素偶联物及其制备方法和应用
CN108324694A (zh) * 2018-04-13 2018-07-27 成都乾坤动物药业股份有限公司 一种土霉素缓释片及其制备方法与用途
CN108379593A (zh) * 2018-05-28 2018-08-10 青岛科技大学 一种制备氟苯尼考-壳聚糖/长链羧酸纳米胶束冻干粉的方法
CN109700783A (zh) * 2019-03-04 2019-05-03 江西派尼生物药业有限公司 一种壳聚糖包被替米考星微球的制备方法
CN114533679B (zh) * 2022-01-28 2023-03-14 马超锋 一种磺胺氯哒嗪缓释纳米胶粒及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06321810A (ja) * 1992-09-24 1994-11-22 Bayer Kk 鶏の筋胃破砕力を利用した持効性製剤
GB9500863D0 (en) * 1995-01-17 1995-03-08 Grampian Pharm Ltd Medicated animal foodstuffs
DE10328666A1 (de) * 2003-06-26 2005-01-13 Bayer Healthcare Ag Tabletten enthaltend Geschmacks-und/oder Aromastoffe
CA2615358C (en) * 2005-07-15 2011-11-08 Fisher Feeds Limited Animal feed
CN1969851A (zh) * 2005-11-25 2007-05-30 天津市润拓生物技术有限公司 一种畜禽使用的恩诺沙星结肠靶向丸剂制备方法
WO2007106452A2 (en) * 2006-03-10 2007-09-20 Archer-Daniels-Midland Company Methods and compositions for increased productivity in animals
CA2662827C (en) * 2006-09-07 2015-04-07 Merial Limited Soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations
CN101744772A (zh) * 2008-11-27 2010-06-23 河南农业大学 一种制备兽用药物缓释微粒的方法
CN102648896A (zh) * 2011-02-28 2012-08-29 郑州福源动物药业有限公司 一种畜禽使用的恩诺沙星缓释微丸及其制备方法

Also Published As

Publication number Publication date
BR112015010980A2 (pt) 2017-07-11
CN105050599A (zh) 2015-11-11
DOP2015000111A (es) 2015-11-15
US20160279063A1 (en) 2016-09-29
MX347401B (es) 2017-04-18
SV2015004970A (es) 2017-07-10
BR112015010980A8 (pt) 2019-10-01
WO2014077666A1 (es) 2014-05-22

Similar Documents

Publication Publication Date Title
MX347401B (es) Composicion de vehiculos y formas farmaceuticas de liberacion sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros farmacos en aves comericales y cerdos.
MX350589B (es) Copolimeros funcionales pla-peg, las nanoparticulas de los mismos, su preparacion y su uso para la administracion dirigida de farmacos e imagenologia.
MX2014011815A (es) Composiciones farmaceuticas de liberacion inmediata con propiedades disuasivas de abuso.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2015010083A (es) Nanoparticulas biodegradables y clinicamente compatibles como portadores para administracion de farmacos.
MX359288B (es) Forma iv del clorhidrato de ivabradina.
TN2012000488A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
TN2015000090A1 (en) Daptomycin formulations and uses thereof
TN2015000135A1 (en) Modified release formulations for oprozomib
WO2014177585A3 (en) Biocatalytic production of nucleoside analogues as active pharmaceutical ingredients
AR105203A1 (es) Formulación oral sólida que contiene irinotecán y método de preparación de la misma
HK1191868A1 (zh) 芍藥苷類化合物在製備抗腫瘤藥物中的用途
MX2018011799A (es) Formas de dosificacion de liberacion prolongada disuasivas de abuso.
MY196998A (en) Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
BR112014021497A2 (pt) sistema de entrega de fármaco baseado em jcv-vlp
MX2018006445A (es) Oligonucleotidos antisentido de interleucina-34 (il-34) y metodos de uso de los mismos.
ME02057B (me) Farmaceutska kompozicija sa antimikrobnim djelovanjem i za ubrzano zacjeljivanje, za spoljašnju administraciju, procesi za njeno dobijanje
EP2476419A4 (en) PHARMACEUTICAL COMPOSITION WITH ANTIMICROBIAL AND ANTI-INFLAMMATORY EFFECT FOR PARENTERAL ADMINISTRATION AND MANUFACTURING METHOD THEREFOR
FR3011736B1 (fr) Seringue d'administration orale de produit
WO2012108631A3 (en) Pharmaceutical compositions comprising revaprazan-containing nanoparticles and processes for the preparation thereof
ECSP17008187A (es) Formas de dosificación farmacéutica
WO2016020936A3 (en) A novel oral gastroretentive pharmaceutical dosage form
PT2802558T (pt) Compostos com atividade antibacteriana, processo para a sua preparação, e composições farmacêuticas compreendendo os mesmos
EP2620152A4 (en) ANTIMICROBIAL ACTION PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION, AND PRODUCTION METHOD
UA108238C2 (xx) Антибактеріальна композиція

Legal Events

Date Code Title Description
FG Grant or registration